Published On : January 2018 Pages : 100 Category: Medical Devices Report Code : HC01513
Industry Outlook and Trend Analysis
The global Neurovascular Devices market was worth USD billion in 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. This development can be linked to an expanding persistent base with neurovascular diseases, for example, strokes and brain aneurysm, enhancing social insurance foundation over the globe, and expanding interest for insignificantly invasive surgeries. Rising number of target patient population, particularly in the created nations, ascribed to expanding awareness about the sicknesses is one of the key components adding to the development of this industry. Constant adoption of the novel and creative treatment approaches combined with expanding per capita incomes particularly in the emerging economies additionally improves the adoption of neurovascular devices.
Device type Outlook and Trend Analysis
Based on type, the neurovascular devices can be sectioned into four significant classes, to be specific, cerebral angioplasty and stenting systems, cerebral embolization and aneurysm coiling devices, support devices, and neurothrombectomy devices. These classes are additionally fragmented in light of particular applications. Cerebral embolization and aneurysm coiling devices represented lion's share at over %, relating to their broad applications fundamentally in the treatment of strokes and aneurysms.
Therapeutic Applications Outlook and Trend Analysis
In 2017 Stroke was the second worldwide cause for death, representing % of deaths around the world. As per American Stroke Association, stroke is fifth reason for death in United States. Moreover, stroke is the main source of inability over the globe. Stroke held the larger part of offer in the fragment for therapeutic applications in 2017, and will hold its position amid the conjecture time frame, inferable from the rising way of life issue identified with blood pressure and obesity.
Regional Outlook and Trend Analysis
North America represents the biggest business share at display and is probably going to hold its best position over the gauge time frame. The key variables driving the development of North American market involve positive repayment structure, particularly in the United States., accessibility of R&D investments, and expanding implementation of neurovascular devices by neurosurgeons because of the innovative modernity. Moreover, the Asia Pacific is foreseen to exhibit significant development in the upcoming years.
Competitive Insights
The leading players in the market are MicroPort Scientific, Terumo Corporation, W. L. Gore and Associates, Abbott and Penumbra. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Neurovascular Devices market is segmented as follows-
By Device Type:
By Therapeutic Application:
By Region
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Ongoing Product Development and Commercialization
3.2.1.2. Expansion of Healthcare Infrastructure Across Emerging Markets
3.2.2. Restraints
3.2.2.1. Dearth of Skilled Neurosurgeons
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
3.2.3.2. Rising Demand for Minimally Invasive Neurosurgical Procedures
4. Neurovascular Devices Market, By Type
4.1. Introduction
4.2. Global Neurovascular Devices Sales, Revenue and Market Share by Type(2017-2017)
4.2.1. Global Neurovascular Devices Sales and Sales Share by Type(2017-2017)
4.2.2. Global Neurovascular Devices Revenue and Revenue Share by Type(2017-2017)
4.3. Neurovascular Devices Market Assessment and Forecast, By Type, 2017-2023
4.4. Cerebral Embolization and Aneurysm Coiling Devices
4.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.5. Cerebral Angioplasty and Stenting Systems
4.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.6. Neurothrombectomy Devices
4.6.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.7. Support Devices
4.7.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5. Neurovascular Devices Market, By Application
5.1. Introduction
5.2. Global Neurovascular Devices Sales, Revenue and Market Share by Application (2017-2017)
5.2.1. Global Neurovascular Devices Sales and Sales Share by Application (2017-2017)
5.2.2. Global Neurovascular Devices Revenue and Revenue Share by Application (2017-2017)
5.3. The Neurovascular Devices Market Assessment and Forecast, By Application, 2017-2023
5.4. Stroke
5.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.5. Cerebral Artery Stenosis
5.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.6. Cerebral Aneurysm
5.6.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.7. Other Applications
5.7.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
6. Neurovascular Devices Market, By Region
6.1. Introduction
6.2. Neurovascular Devices Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.3. Global Neurovascular Devices Sales, Revenue and Market Share by Regions
6.3.1. Global Neurovascular Devices Sales by Regions (2017-2017)
6.3.2. Global Neurovascular Devices Revenue by Regions (2017-2017)
6.4. North America
6.4.1. North America Neurovascular Devices Sales and Growth Rate (2017-2017)
6.4.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.4.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.5. U.S.
6.4.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.6. Canada
6.4.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.4.7. Mexico
6.4.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5. Europe
6.5.1. Europe Neurovascular Devices Sales and Growth Rate (2017-2017)
6.5.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.5.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.5. Germany
6.5.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.6. France
6.5.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.7. UK
6.5.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.8. Italy
6.5.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.9. Spain
6.5.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.5.10. Rest of Europe
6.5.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Neurovascular Devices Sales and Growth Rate (2017-2017)
6.6.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.6.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.5. Japan
6.6.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.6. China
6.6.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.7. Australia
6.6.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.8. India
6.6.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.9. South Korea
6.6.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.6.10. Rest of Asia-Pacific
6.6.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7. Rest of the World
6.7.1. Rest of the World Neurovascular Devices Sales and Growth Rate (2017-2017)
6.7.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.7.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.4. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.5. Brazil
6.7.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.5.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.6. Turkey
6.7.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.6.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.7. Saudi Arabia
6.7.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.7.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.8. South Africa
6.7.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.8.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.9. United Arab Emirates
6.7.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.9.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
6.7.10. Others
6.7.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.10.2. Market Assessment and Forecast, By Application, 2017-2023($Million)
7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Neurovascular Devices Sales, Revenue and Market Share
7.2. W. L. Gore & Associates, Inc.
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Neurovascular Devices Sales, Revenue and Market Share
7.3. Johnson and Johnson
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Neurovascular Devices Sales, Revenue and Market Share
7.4. Medtronic
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Neurovascular Devices Sales, Revenue and Market Share
7.5. Merit Medical Systems, Inc.
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Neurovascular Devices Sales, Revenue and Market Share
7.6. Microport Scientific Corporation
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Neurovascular Devices Sales, Revenue and Market Share
7.7. Penumbra, Inc.
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Neurovascular Devices Sales, Revenue and Market Share
7.8. Stryker Corporation
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Neurovascular Devices Sales, Revenue and Market Share
7.9. Terumo Corporation
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.9.4. Neurovascular Devices Sales, Revenue and Market Share
8. Global Neurovascular Devices Market Competition, by Manufacturer
8.1. Global Neurovascular Devices Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Neurovascular Devices Revenue and Market Share by Manufacturer (2017-2017)
8.3. Top 5 Neurovascular Devices Manufacturer Market Share
8.4. Market Competition Trend
List of Tables
Table: Global Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Global Neurovascular Devices Sales and Sales Share by Type (2017-2017)
Table: Global Neurovascular Devices Revenue and Revenue Share by Type (2017-2017)
Table: Cerebral Embolization and Aneurysm Coiling Devices Market, By Region, 2017-2023($Million)
Table: Cerebral Angioplasty and Stenting Systems Market, By Region, 2017-2023($Million)
Table: Neurothrombectomy Devices Market, By Region, 2017-2023($Million)
Table: Support Devices Market, By Region, 2017-2023($Million)
Table: Global Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Global Neurovascular Devices Sales and Sales Share by Application (2017-2017)
Table: Global Neurovascular Devices Revenue and Revenue Share by Application (2017-2017)
Table: Stroke Market, By Region, 2017-2023($Million)
Table: Cerebral Artery Stenosis Market, By Region, 2017-2023($Million)
Table: Cerebral Aneurysm Market, By Region, 2017-2023($Million)
Table: Other Applications Market, By Region, 2017-2023($Million)
Table: Global Neurovascular Devices Sales, Revenue and Market Share by Regions
Table: North America Neurovascular Devices Sales and Growth Rate (2017-2017)
Table: North America Neurovascular Devices Market, By Country, 2017-2023($Million)
Table: North America Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: North America Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: U.S. Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: U.S. Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Canada Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Canada Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Mexico Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Mexico Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Europe Neurovascular Devices Sales and Growth Rate (2017-2017)
Table: Europe Neurovascular Devices Market, By Country, 2017-2023($Million)
Table: Europe Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Europe Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Germany Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Germany Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: France Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: France Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: UK Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: UK Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Italy Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Italy Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Spain Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Spain Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Rest of Europe Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Rest of Europe Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Asia-Pacific Neurovascular Devices Sales and Growth Rate (2017-2017)
Table: Asia-Pacific Neurovascular Devices Market, By Country, 2017-2023($Million)
Table: Asia-Pacific Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Asia-Pacific Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Japan Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Japan Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: China Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: China Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Australia Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Australia Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: India Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: India Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: South Korea Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: South Korea Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Rest of Asia-Pacific Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Rest of Asia-Pacific Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Rest of the World Neurovascular Devices Sales and Growth Rate (2017-2017)
Table: Rest of the World Neurovascular Devices Market, By Country, 2017-2023($Million)
Table: Rest of the World Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Rest of the World Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Brazil Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Brazil Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Turkey Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Turkey Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Saudi Arabia Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Saudi Arabia Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: South Africa Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: South Africa Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: United Arab Emirates Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: United Arab Emirates Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Others Neurovascular Devices Market, By Type, 2017-2023($Million)
Table: Others Neurovascular Devices Market, By Application, 2017-2023($Million)
Table: Abbott Laboratories: Key Strategic Developments, 2017-2017
Table: W. L. Gore & Associates, Inc.: Key Strategic Developments, 2017-2017
Table: Johnson and Johnson: Key Strategic Developments, 2017-2017
Table: Medtronic: Key Strategic Developments, 2017-2017
Table: Merit Medical Systems, Inc.: Key Strategic Developments, 2017-2017
Table: Microport Scientific Corporation: Key Strategic Developments, 2017-2017
Table: Penumbra, Inc.: Key Strategic Developments, 2017-2017
Table: Stryker Corporation: Key Strategic Developments, 2017-2017
Table: Terumo Corporation: Key Strategic Developments, 2017-2017
List of Figures
Figure: Global Neurovascular Devices Market Share, By Type, 2017 & 2023
Figure: Global Neurovascular Devices Market, By Application, 2017 & 2023 ($Million)
Figure: Global Neurovascular Devices Market, By Region, 2017 & 2023 ($Million)
Figure: Global Neurovascular Devices Sales and Sales Share by Type (2017-2017)
Figure: Global Neurovascular Devices Revenue and Revenue Share by Type (2017-2017)
Figure: Global Neurovascular Devices Sales and Sales Share by Application (2017-2017)
Figure: Global Neurovascular Devices Revenue and Revenue Share by Application (2017-2017)
Figure: North America Neurovascular Devices Sales and Growth Rate (2017-2017)
Figure: Europe Neurovascular Devices Sales and Growth Rate (2017-2017)
Figure: Asia-Pacific Neurovascular Devices Sales and Growth Rate (2017-2017)
Figure: Rest of the World Neurovascular Devices Sales and Growth Rate (2017-2017)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|